KESSINGLAND PHARMA LTD Financials
- Company number
- 14467019CopyCopy
- Registered office
- 205 Plumstead Road, Norwich NR1 4AB
- Incorporated
- 07/11/2022
Company snapshot
- Status
- Active
- Employees
- 8 (2025)
- Latest financial data
- 2025
- Accounts type
- Micro Entity
Financial highlights
Latest reported figures. Okredo holds filed data for 2023–2025.
Net Assets
93.13%vs 20242024: £207.73K
Total Assets
-4.85%vs 20242024: £1.53M
Cash in Bank
88.18%vs 20232023: £72.26K
Total Liabilities
-18.92%vs 20242024: £1.30M
Employees
0vs 20242024: 8
In 2025, KESSINGLAND PHARMA LTD reported net assets of £401.18K. The same filing shows total assets of £1.45M, cash in bank of £135.99K and total liabilities of £1.05M. Reported headcount was 8 in 2025. Total Liabilities fell from £1.30M in 2024 to £1.05M in 2025 (-18.92%). Okredo holds filed figures for 2023–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
93.13%from £207.73K in 2024Year-on-year change
Net Assets as filed for 2023–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures KESSINGLAND PHARMA LTD filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+650%vs 2023+174% a year compound (CAGR)
Total Assets
-2.4%vs 2023-1.2% a year compound (CAGR)
Total Liabilities
-25.6%vs 2023-13.7% a year compound (CAGR)
Employees
0%vs 2023Biggest increase
Net Assets+650%
£53.48K in 2023 to £401.18K in 2025
Biggest decrease
Total Liabilities-25.6%
£1.41M in 2023 to £1.05M in 2025
KESSINGLAND PHARMA LTD's filings pull in both directions between 2023 and 2025. The steepest rise came in net assets, pointing to a strengthening balance sheet, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.
Ratios from the filed figures
Calculated from KESSINGLAND PHARMA LTD's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 27.58%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 72.42%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 10.47%2024
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 8.90%2024
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for KESSINGLAND PHARMA LTD by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Assets£ | 53.48K | 207.73K | 401.18K |
| Total Assets£ | 1.49M | 1.53M | 1.45M |
| Cash in Bank£ | 72.26K | 135.99K | – |
| Total Liabilities£ | 1.41M | 1.30M | 1.05M |
| Employees | 8 | 8 | 8 |
KESSINGLAND PHARMA LTD financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for KESSINGLAND PHARMA LTD covering 2023–2025, across 5 reported indicators. The most recent reported year is 2025.
KESSINGLAND PHARMA LTD reported net assets of £401.18K for 2025. That compares with £207.73K in 2024, a change of 93.13%.
KESSINGLAND PHARMA LTD reported total assets of £1.45M for 2025. That compares with £1.53M in 2024, a change of -4.85%.
KESSINGLAND PHARMA LTD reported cash in bank of £135.99K for 2024. That compares with £72.26K in 2023, a change of 88.18%.
KESSINGLAND PHARMA LTD reported 8 employees in 2025, compared with 8 in 2024.
Between 2023 and 2025, KESSINGLAND PHARMA LTD's net assets rose by 650%, total assets fell by 2.4%, total liabilities fell by 25.6% and employee numbers was unchanged. Net assets compounded at 174% a year across the two years to 2025, from £53.48K to £401.18K. Reported headcount went from 8 in 2023 to 8 in 2025.
Okredo holds reported figures for the years 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.